FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, namely to immunology, and can be used for obtaining medication for preventive treatment of tuberculosis. Immunotherapeutic medication contains fragments of cell wall of Mycobacterium tuberculosis complex (MTB-C).
EFFECT: claimed medication is obtained by method including the following stages: cultivation of virulent strain of MTB-C for the period, equal or longer than three weeks, and homogenisation of cell culture in presence of non-ionic surface-active substance.
14 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOTHERAPEUTIC AGENT FOR PRIMARY PREVENTION OF TUBERCULOSIS | 2009 |
|
RU2544125C2 |
| IMMUNOTERAPEUTIC AGENT SUITABLE FOR COMBINED TUBERCULOSIS TREATMENT COUPLED WITH OTHER MEDICAL PRODUCTS | 2004 |
|
RU2341287C2 |
| LIPOSOME FORMULATION SUITABLE FOR TREATING OR PREVENTING TUBERCULOSIS | 2012 |
|
RU2648842C2 |
| MTB-C VACCINE AGAINST ASTHMA | 2012 |
|
RU2602771C2 |
| ANTITUBERCULOUS VACCINE | 2007 |
|
RU2443773C2 |
| STRAIN OF MYCOBACTERIUM TUBERCULOSIS BN FOR MODELLING LATENT TUBERCULOSIS INFECTION | 2021 |
|
RU2760751C1 |
| COMPOSITIONS FOR USE AS A PREVENTIVE AGENT FOR PATIENTS WITH A RISK OF TB INFECTION OR AS A SECONDARY AGENT FOR THE TREATMENT OF PATIENTS WITH TB INFECTION | 2019 |
|
RU2778094C2 |
| RECOMBINANT INFLUENZA VIRUS STRAINS EXPRESSING MYCOBACTERIAL PROTECTIVE ESAT-6 ANTIGEN AND USES THEREOF IN TUBERCULOSIS TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2318872C2 |
| VACCINES OF RECOMBINANT INTRACELLULAR PATHOGENS AND USES THEREOF | 2001 |
|
RU2266132C2 |
| METHOD FOR OBTAINING VACCINE FOR TREATING TUBERCULOSIS AND OTHER INTRACELLULAR INFECTIOUS DISEASES AND VACCINE OBTAINED ACCORDING TO DECLARED METHOD | 2001 |
|
RU2262950C2 |
